Purpose:
To describe the results of an intravitreal dexamethasone implant in managing autoimmune retinopathy (AIR).
Methods:
Two patients affected by AIR underwent intravitreal dexamethasone implantation and were followed by ocular coherence tomography, visual fields, and electroretinography.
Results:
The patients showed an interruption of the functional losses and remained stable with semestral injections.
Conclusion:
AIR is a complex condition with no standard treatment. The use of dexamethasone could be a valid option.